Hardware-aware threat intel for ICS/SCADA environments. 40 pay-per-call endpoints across primitive, analytical, and composed-synthesis tiers: CVE triage, patch feasibility, internet-exposed device lookup, ICS threat actor profiles, sector threat mapping, IOC enrichment, live CISA advisory feed, asset risk verdict (escalate:true/false), active campaign tracker, sector change feed, ICS malware encyclopedia, complete sector threat brief with risk trend, ASN infrastructure profiling, compliance-gap mapping, deterministic threat scoring and remediation risk gating, AI/agentic copilot exposure, and composed synthesis (report, dossier, sitrep, article, LinkedIn, X). DeepSeek-enriched. No API keys — pure USDC micropayments on Base via x402.

LVL LTD CO operates lvlltd.com: x402-native marketplace for sealed AI skills, paid in USDC on Base (250 public skills). Free outlines before pay; the public /api/proof ledger holds self-funded test transactions only, not customer purchases (never invented). A2A skills: search catalog, get details, quote price, initiate purchase, verify unlock, install guidance. Payment settles via x402 HTTP — not inside A2A JSON-RPC. Optional AP2 mandates and ERC-8004 identity are additive. Small product lab; honest identity: https://lvlltd.com/about/ · https://lvlltd.com/about.json

Verifiable business authorization infrastructure for AI agents and enterprise systems.

Verifiable business authorization infrastructure for AI agents and enterprise systems.

Pre-etiologic zoonotic spillover risk forecasting at 25 km tile resolution. Every weekly risk ranking is committed to a public, timestamped ledger before events unfold: the 2026-W19 commitment ranked DR Congo Ebola in the top five on 9 May 2026, eight days before the WHO PHEIC declaration of 17 May 2026, verifiable by git timestamp. Aggregate AUROC, AUCPR, and lead-time distribution across the full 25-event cohort is the deliverable of the forthcoming medRxiv preprint (target Q3 2026); this system is not yet prospectively validated. Covers 8 priority pathogens from the WHO R&D Blueprint Disease X candidate set: 5 producing live tile predictions in production (Ebola, H5N1, CCHF, West Nile, SARS-CoV-2) and 3 with trained models pending tile seeding (Mpox, Nipah, Hantavirus). Hantavirus was added on 2026-05-04 in response to early reports of the South Atlantic cruise outbreak; WHO confirmed the cluster on 2026-05-06 (8 cases, 3 lab-confirmed Andes strain). Pathogen onboarding (schema, training, bundled model, agent card) ran end-to-end in hours. Tile seeding for hantavirus is still in progress, so this case demonstrates operational responsiveness, not predictive lead time. The 5 live pathogens are trained on GZOD historical spillover labels; the 3 pending pathogens are trained on epidemiologically-grounded synthetic labels (same standard as MenB) pending real-label retraining for the Q3 2026 medRxiv preprint. See `prediction_status` and the training-script citations on each entry. Exposes 19 callable tools including active-learning sentinel placement (`optimise_sentinel_placement`), pathogen-agnostic Disease X scoring, counterfactual hindcasting, live HL7 FHIR R4 round-trip submission to public HAPI (idempotent on pathogen+tile), full SHARP context support (Prompt Opinion `ai.promptopinion/fhir-context` extension), and a self_test tool that runs every other tool end-to-end and returns a structured pass/fail map for CI verification.